Innate Pharma SA
F:IDDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
F:IDDA
|
FR |
|
Petro Rio SA
OTC:PTRRY
|
BR |
|
I
|
Ibiden Co Ltd
XMUN:IBI
|
JP |
|
S
|
Sydbank A/S
F:TM2
|
DK |
|
G
|
Genesco Inc
F:GN8
|
US |
|
T
|
TUI AG
XMUN:TUI1
|
DE |
|
M
|
Mawson Gold Ltd
F:MXR
|
CA |
|
DFS Furniture PLC
F:DF0
|
UK |
|
Calnex Solutions PLC
F:CSO
|
UK |
|
K
|
Koppers Holdings Inc
F:KO9
|
US |
|
O
|
Omni Bridgeway Ltd
F:MXG1
|
AU |
|
A
|
adesso SE
XMUN:ADN1
|
DE |
|
A
|
Admiral Group PLC
F:FLN
|
UK |
|
M
|
Maat Pharma SA
F:4RD
|
FR |
|
NioCorp Developments Ltd
F:BR30
|
US |
|
E
|
Eneti Inc
F:SR4
|
MC |
|
D
|
DKSH Holding AG
XMUN:DS5
|
CH |
|
B
|
Banca Monte dei Paschi di Siena SpA
F:MPIN
|
IT |
Shareholder Yield
Current shareholder yield for 
IDDA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IDDA Price
Innate Pharma SA
| Average Annual Return | -7.33% |
| Standard Deviation of Annual Returns | 31.89% |
| Max Drawdown | -86% |
| Market Capitalization | 147.7m EUR |
| Shares Outstanding | 80 950 800 |
| Percentage of Shares Shorted |
N/A
|
